跳至主要内容
临床试验/NCT02257047
NCT02257047Unknown不适用

Red Yeast Rice and Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Chengdu PLA General Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2014年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Changes from baseline in Carotid intima-media thickness at 24 weeks

研究概览

简要总结

To evaluate the effect of red yeast rice on subclinical atherosclerosis in patients with rheumatoid arthritis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a definite diagnose of rheumatoid arthritis(RA) were included if they met the classification criteria for RA established by the American Rheumatism Association (ACR) and European League Against Rheumatism (EULAR) in 2010
  • aged from 18 to 75 years
  • without conflict to the written, informed consent signed prior to the enrollment
  • no severe hepatic or renal disorders
  • no known carotid artery stenosis
  • no coagulation disorders
  • no hypertension

排除标准

  • being in pregnancy, lactation period or under a pregnancy plan
  • being allergic to the test drug
  • not compatible for the trial medication
  • without full legal capacity

研究组 & 干预措施

RYR

Experimental

Patients under the treatment of red yeast rice

干预措施: RYR (Dietary Supplement)

Control

Sham Comparator

Patients under the treatment of tea

干预措施: Tea (Dietary Supplement)

结局指标

主要结局

Changes from baseline in Carotid intima-media thickness at 24 weeks

时间窗: At 0 week, 12 weeks, 24 weeks

次要结局

未报告次要终点

研究者

发起方
Chengdu PLA General Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yang Min

Ph.D

Chengdu PLA General Hospital

研究点 (1)

Loading locations...

相似试验